The Enriched Sequencing Method for Detection of K-Ras Mutations Enhances the Identification of Primary Resistant Colorectal Cancers to Panitumumab
Luciano Stumbo(Ospedale San Filippo Neri), Antonio Marchetti(Agostino Gemelli University Polyclinic), Ida Pavese(Ospedale San Pietro Fatebenefratelli), Roberto Bordonaro(Ospedale Garibaldi), Lara Felicioni(University of Chieti-Pescara), G. Sanna(Azienda Ospedaliero Universitaria di Sassari), Mario Airoldi, Angela Buonadonna(Centro di Riferimento Oncologico), Mario D’Andrea(Ospedale San Filippo Neri), V. Leonardi(University of Palermo), Roberto Labianca(Ospedale Papa Giovanni XXIII), Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), Stefano Jacobelli(Presidio Ospedaliero), Salvatore Tumolo, Giampietro Gasparini(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 0
Related Papers
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k